💡 A daily brightening lotion from CIRCADIA built for clients managing hyperpigmentation — formulated with a four-pathway active system that targets melanin at every stage, from receptor signaling down to gene-level regulation.

Where single-active brighteners stall, Radiant Veil Brightener works across parallel mechanisms: Alpha-Arbutin and a stabilized Vitamin C derivative inhibit tyrosinase directly; Niacinamide blocks melanin transfer to skin cells; SepiWhite MSH intercepts the hormonal trigger upstream; and Oligopeptide-68 (B-White) suppresses the transcription factor that drives pigmentation gene expression. That stacked architecture makes it a credible home-maintenance anchor after in-clinic peels, laser sessions, or microneedling — keeping the work you did in the treatment room from reverting between visits.

✨ The lightweight, fast-absorbing lotion base layers cleanly under morning SPF or over evening serums, fitting naturally into any brightening protocol without disrupting layering order.

A strong retail close for post-peel and post-laser clients who need a maintenance step they'll actually commit to.

• Reduces the appearance of dark spots and hyperpigmentation: A layered active system targets melanin production at multiple stages — from blocking the initial hormonal signal that triggers pigment production, to inhibiting the tyrosinase enzyme directly, to slowing the transfer of melanin to skin cells. Working together, these mechanisms help visibly fade dark spots, post-inflammatory marks, and areas of uneven pigmentation with regular use.
• Brightens and evens overall skin tone: By addressing melanin formation and distribution through complementary mechanisms — including a gene-level peptide active (B-White/Oligopeptide-68) that reduces both baseline and UV-triggered pigmentation — the formula helps create a more uniform, luminous complexion over time.
• Provides antioxidant support to protect against oxidative pigmentation triggers: The stabilized Vitamin C derivative (K3 Vita C/Aminopropyl Ascorbyl Phosphate) contributes antioxidant activity alongside its brightening function, helping neutralize oxidative factors that can contribute to pigment formation and uneven tone.
• Lightweight, fast-absorbing texture suitable for daily morning and evening use: The lotion base is formulated with silicone polymers and light emollients that allow quick absorption without heavy residue, making it compatible with layering under sunscreen in a morning routine or over serums in an evening protocol.

Alpha-Arbutin - known as Alpha-Arbutin: A concentrated tyrosinase-inhibiting active that reduces the appearance of dark spots and uneven pigmentation by limiting melanin production at the source.: Alpha-Arbutin occupies a high position in the INCI list (position 4), indicating functional concentration. It inhibits tyrosinase — the key enzyme in melanin synthesis — to visibly reduce the appearance of hyperpigmentation, dark spots, and uneven tone. Considered a benchmark brightening agent in professional skincare for its reliable efficacy and favorable tolerability profile.

Niacinamide - known as Niacinamide: A multifunctional brightening active that reduces the transfer of melanin to skin cells, visibly fading dark spots and helping even skin tone over time.: Listed at position 5 in the INCI, indicating a functional working concentration. Niacinamide acts as a melanosome transfer inhibitor — it disrupts the handoff of melanin-containing granules from pigment-producing cells to surrounding skin cells, reducing the appearance of discoloration without directly interfering with tyrosinase. Widely recognized as a cornerstone ingredient in hyperpigmentation-focused formulations and complements tyrosinase-inhibiting actives through a distinct, parallel mechanism.

Undecylenoyl Phenylalanine - known as SepiWhite MSH: A peptide-derived brightening active that targets melanin regulation upstream by acting as an antagonist at melanocyte receptors, reducing the stimulus that triggers tyrosinase production.: Marketed under the trade name SepiWhite MSH, this ingredient binds to the melanocyte-stimulating hormone receptor (MC1-R), blocking the signal cascade that would otherwise initiate tyrosinase production and subsequent melanin synthesis. This upstream mechanism is distinct from direct enzyme inhibition, making it a meaningful complement to Alpha-Arbutin and Niacinamide. Listed at position 6, above the estimated 1% line, supporting a functional working level. Trace-effective by class (peptide-analog ingredient engineered for sub-percent activity).

Oligopeptide-68 - known as B-White (Oligopeptide-68): A biotech-derived peptide active that reduces melanin synthesis by targeting the transcription factor that controls pigmentation gene expression, addressing both everyday and UV-triggered pigmentation.: Marketed under the trade name B-White, Oligopeptide-68 works at the gene-regulation level by reducing the activity of MITF (microphthalmia-associated transcription factor), the master regulator of melanogenesis. This results in decreased expression of tyrosinase and related enzymes, reducing both baseline (constitutive) and sun-triggered (facultative) pigmentation. As a peptide active, it functions at trace concentrations by design. Listed deep in the INCI (position 29), consistent with peptide dosing norms.

Aminopropyl Ascorbyl Phosphate - known as K3 Vita C: A stabilized phosphate ester form of Vitamin C that inhibits tyrosinase to reduce the appearance of pigmentation while also providing antioxidant support.: Listed under the trade name K3 Vita C, this is a stabilized, water-soluble vitamin C derivative (aminopropyl ascorbyl phosphate) that delivers the brightening action of ascorbic acid in a more stable form. Like classic Vitamin C, it inhibits tyrosinase, contributing to an additional brightening pathway that complements the melanosome-transfer inhibition of Niacinamide and the receptor-level action of SepiWhite. Its stabilized ester form also provides antioxidant activity, helping to neutralize oxidative contributors to pigment formation. Listed at position 15, which by formulation convention is near or just below the 1% line; however, as a trace-effective stabilized vitamin C derivative engineered for sub-percent activity, it passes the concentration screen.

Dimethylmethoxy Chromanyl Palmitate - known as Chromabright: A vitamin E-derived brightening active that inhibits tyrosinase through a mechanism similar to ascorbyl palmitate, contributing to overall skin clarity and tone correction.: Marketed under the trade name Chromabright, this lipid-soluble chroman derivative inhibits tyrosinase to reduce the appearance of hyperpigmentation. Its palmitate ester structure provides good skin penetration, supporting delivery in a leave-on lotion. It adds a fourth, structurally distinct brightening mechanism to the formula — lipid-phase tyrosinase inhibition — that works alongside the aqueous-phase actives. Trace-effective by class; positioned at 21 in the INCI, consistent with use-level norms for this ingredient type.

1. Ensure the client's face and neck are clean and any treatment serums have been applied and absorbed prior to this step.
2. Dispense a dime-sized amount of product onto fingertips.
3. Apply evenly over the face and neck using gentle upward strokes.
4. Avoid the eye area during application.
5. For evening use, this is the final step in the treatment protocol.
6. For morning use, follow immediately with a broad-spectrum SPF product over the top.

Integrating into a brightening treatment protocol

This lotion works well as the daily home-maintenance step following in-clinic brightening services such as chemical peels, laser treatments, or microneedling. When prescribing it post-procedure, advise clients to wait until the skin barrier has fully re-stabilized before starting — typically 5–7 days after a medium-depth peel or as directed by protocol. For clients managing melasma or deeper dyschromia, pairing this lotion with a morning SPF 50+ broad-spectrum sunscreen is essential; without consistent sun protection, UV-triggered melanogenesis will counteract the formula's multi-mechanism inhibition.

For in-service retail conversion: after a brightening facial, walk the client through the stacked active system — most clients are impressed by the four-pathway explanation (melanosome transfer, tyrosinase inhibition, receptor antagonism, gene-level regulation) and it reinforces the clinical credibility of the recommendation. This is a practical upsell anchor for post-peel and post-laser maintenance programs.